|
KLF5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.086000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.889000E-01 |
| Normal-vs-Stage2 |
1.966850E-04 |
| Normal-vs-Stage3 |
6.519600E-02 |
| Normal-vs-Stage4 |
1.619590E-01 |
| Stage1-vs-Stage2 |
8.17459999999937E-05 |
| Stage1-vs-Stage3 |
8.885500E-02 |
| Stage1-vs-Stage4 |
2.436800E-01 |
| Stage2-vs-Stage3 |
5.618200E-03 |
| Stage2-vs-Stage4 |
6.044700E-03 |
| Stage3-vs-Stage4 |
7.717600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.916800E-01 |
| Normal-vs-AfricanAmerican |
8.481600E-01 |
| Normal-vs-Asian |
3.991600E-01 |
| Caucasian-vs-AfricanAmerican |
7.852800E-01 |
| Caucasian-vs-Asian |
6.937400E-01 |
| AfricanAmerican-vs-Asian |
6.522800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.107000E-01 |
| Normal-vs-Female |
2.319400E-01 |
| Male-vs-Female |
8.583400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.672800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.239500E-02 |
| Normal-vs-Age(61-80Yrs) |
9.166500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.624200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.087600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.838660E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.761800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.062200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.674000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.020000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.648650E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
5.228200E-01 |
| Classical-VS-Normal |
9.572000E-01 |
| Tall-VS-Follicular |
3.01839999661269E-08 |
| Tall-VS-Other |
4.096000E-01 |
| Tall-VS-Normal |
3.519000E-01 |
| Follicular-VS-Other |
4.825900E-02 |
| Follicular-VS-Normal |
6.54270000399748E-08 |
| Other-VS-Normal |
4.695200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.656500E-03 |
| Normal-vs-N1 |
8.786400E-01 |
| N0-vs-N1 |
3.604500E-03 |
|
|
